News & Perspective

May 08, 2008

May 08, 2008

Smallpox drug does well in first human safety test

(CIDRAP News) – An antiviral drug being developed to provide protection against smallpox and related viruses performed well in the first test of its safety and activity in humans, according to a report in the May issue of Antimicrobial Agents and Chemotherapy.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»